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ABSTRACT: In this study, an automated intelligent decision support (IDS) framework was applied to monitor the continuous
crystallization of form I paracetamol (PCM) and determine steady-state operation. A modified single-stage mixed suspension
mixed product removal (MSMPR) crystallizer was used to investigate methods to minimize early onset of fouling and
encrustation by carrying out crystallizations in the presence and absence of hydroxyl propyl methyl cellulose (HPMC) additive.
The effectiveness of HPMC toward controlling the crystallization process and alleviating fouling and encrustation for prolonged
operation of the MSMPR was investigated over a range of concentrations. HPMC was found to suppress nucleation and growth,
thereby controlling the crystallization and alleviating fouling and encrustation over extended operating periods. HPMC also
affected the product crystal morphology, leading to predominantly tabular shaped crystals. Steady state in the MSMPR was
characterized using the IDS, which consisted of an integrated and ancillary array of process analytical technologies (PAT),
including the application of Raman spectroscopy with multivariate calibration for solution phase concentration measurement.
1. INTRODUCTION
The operation of batch crystallizers currently employed in
pharmaceutical and other high-value chemical industries is
often labor-intensive, costly, and inefficient. High-level
modeling, monitoring, and control strategies are increasingly
being developed using process analytical technologies (PAT) to
improve batch crystallizer performance. However, similar
concepts can be applied to continuous crystallizers, gaining
the additional benefits related to operating at steady state1−4 or
at least in a controlled dynamic state. There exist significant
opportunities to apply PAT to tailor desired product critical
quality attributes (CQA) such as crystal size distribution
(CSD), shape distribution, and purity in the continuous
crystallization domain. This could likely lead to the develop-
ment of scalable and adaptable continuous crystallizers to meet
current manufacturing challenges, such as reduced product and
process variability, reduced inventory levels, and lower
manufacturing costs. Furthermore, PAT tools are essential for
real-time process monitoring and control, as they supply the
data from which relevant process and product information and
conclusions can be extracted.5,6 In addition to applying PAT for
process monitoring and control, novel continuous crystalliza-
tion operating strategies are required to overcome the
limitations of current technologies. For example, fouling and
encrustation, transfer line blockage, and classified product
withdrawal issues are frequently experienced in the
MSMPR7−11 and tubular flow crystallizer.12−14 Fouling and
encrustation and transfer line blockage are often the result of
the development of high local supersaturation due to
temperature differences within the crystallizer, leading to
uncontrolled nucleation events and encrustation on heat
exchange surfaces.2,15,16 In addition, surface properties of the
crystallizer construction material (such as roughness) are
known to contribute to encrustation issues.16,17 The breaking
off of crusts from the crystallizer walls can then lead to line
blockages as well as particle settling and classification due to the
difference in flow velocities in the agitated crystallizer or in
transfer lines. To overcome these challenges in MSMPR
operation, researchers have used different operating strategies
to varying degrees of success, for example, intermittent
withdrawal9,18,19 and, more recently, periodic flow operation.20
In this study, a two-pronged approach was taken to alleviate
fouling and encrustation in MSMPR. The first involved the
design of a modified MSMPR, incorporating a baffled heat
exchanger to minimize temperature variations that can occur
when incoming feed solution at higher temperature enters the
MSMPR operating at lower temperature. Fouling and
encrustation occur by the following mechanisms: (1)
adsorption onto a surface prone to fouling/encrustation, (2)
adsorption on heterogeneous and secondary nuclei that come
into contact with the surface, and (3) alteration of the surface
structure of the nuclei and crystals.17 The second approach to
fouling and encrustation prevention involved the use of an
additive to control the crystallization kinetics. The polymer
hydroxyl propyl methyl cellulose (HPMC) was identified as a
possible candidate. In their study, Femi-Oyewo et al.21
investigated the effect of additives on the crystallization of
PCM from aqueous solution and in particular on the crystal
structure and processability of PCM raw material in the final
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solid dosage form. HPMC was found to significantly suppress
nucleation and growth of PCM in the concentration range 0.1−
0.7 wt %, resulting in very fine crystals. In the current study, the
aim was to control the crystallization (nucleation and growth)
of PCM to avoid fouling and encrustation for prolonged
operation of the modified MSMPR. Concentrations of HPMC
less than 0.1 wt % were investigated to avoid significant
suppression of nucleation and crystal growth.
A further aim of the work presented here is to demonstrate
how the development and application of a robust monitoring
framework using PAT in combination with multivariate
methods and information systems tool may be applied to
characterize the modified MSMPR crystallizer. For this
purpose, an automated integrated intelligent decision support
system (IDS) consisting of three components was used: (1) an
integrated PAT array based on attenuated total reflectance
ultraviolet/visible (ATR-UV/vis) spectroscopy and focused
beam reflectance measurement (FBRM), (2) a crystallization
process informatics software system (CryPRINS), and (3) an
ancillary PAT array based on Raman spectroscopy and particle
vision microscopy (PVM). These tools were applied to monitor
crystallizations in the modified MSMPR and determine when
steady state (or a “state of controlled operation”20) is achieved.
The IDS allowed for real-time temperature control using RS232
communication between CryPRINS and the thermofluid baths
used to supply coolant to the MSMPR heat transfer jacket.
Until now, integrated PAT array and information systems tools
have primarily been applied to batch crystallizers.22−24 In their
study, Saleemi et al.23 demonstrated the use of an integrated
PAT array consisting of ATR-UV/vis, FBRM, and the
CryPRINS information systems software within an IDS
framework to monitor and control the crystallization of
mixtures of positional isomers. Wu and Khan24 used an
integrated PAT framework consisting of near-infrared spec-
troscopy (NIR), FBRM, and a turbidity sensor to monitor a
coprecipitation process. These investigators concluded that the
use of integrated PAT array and information systems were
essential for knowledge building and process understanding and
for establishing suitable process monitoring and control
strategies. In addition to providing real-time process monitor-
ing and control capabilities, PAT and information systems can
provide detailed information on physical, chemical, and
microbiological properties when multivariate methods are
applied.25−30 Typically, multivariate data analysis algorithms
such as principal component analysis (PCA), partial least-
squares regression (PLSR), principal component regression
(PCR), multiple linear regression (MLR), and variations of
these methods are applied to build calibration models for
process monitoring and closed-loop control. Multivariate
methods when combined with population balance modeling
can also be used to derive mathematical relationships between
certain desired product properties, for example, CSD and
Figure 1. (a) Schematic of modified single-stage MSMPR unit with integrated PAT array and CryPRINS information system tools used for process
monitoring and implementation of temperature control. (b) Flow diagram of MSMPR indicating the operating conditions employed. (c)
Photograph of the lab-scale MSMPR used for the continuous cooling crystallization of PCM.
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contributing variables, such as concentration/supersaturation.25
Information provided by multivariate methods is also useful for
process modeling and optimization. Some investigators have
also explored univariate calibration-free approaches for process
monitoring. A detailed discussion on calibration-free methods
can be found in a recent review by Nagy et al.25 These methods
often assume a linear dependency of signal intensity on the
solute and/or solid concentration, and they cannot cope with
interferences that result in noisy signals or temperature effects.
The inherent advantage of multivariate statistical methods is the
ability to reduce signal noise and select otherwise nonselective
signals to improve calibration model development.31
2. MATERIALS AND METHODS
The continuous cooling crystallization of paracetamol (4-
acetamidophenol (PCM), 98% purity purchased from Sigma-
Aldrich UK) from isopropyl alcohol (propan-2-ol (IPA),
analytical grade, 99.97% purchased from Fisher Scientific UK)
was investigated with and without additives. The additive used
in the study was HPMC (analytical grade, purchased from
Sigma-Aldrich UK). Experiments were carried out using a
modified MSMPR unit, as shown in Figure 1. A recirculation
loop was incorporated in the design so that product slurry
withdrawn from the MSMPR is sent to a dissolver, which also
serves as a feed/recycle unit.1,32,33 Importantly, this arrange-
ment allows the MSMPR to operate as a continuous, unseeded
system for long periods, without using the large quantities of
material often consumed by flow crystallizers. The added value
of the modified MSMPR unit is that continuous crystallization
of high-value active pharmaceutical ingredients (APIs) can be
investigated using only a small amount of material, in particular,
during the preclinical and phase I stages of drug development.
Figure 1a−c shows a schematic layout with PAT tools, flow
diagram, and photograph of the experimental setup used,
respectively. The modified MSMPR consisted of a 750 mL
crystallizer and 400 mL dissolver vessel, each with independent
temperature controllers. The MSMPR was connected to the
dissolver using Masterflex platinum cured silicon tubing (6.4
mm ID). A heat exchanger consisting of a jacketed 220 mm
length glass tube with smooth periodic baffle constrictions (5
mm i.d. with 2.0 mm constrictions) connected to a thermofluid
circulator bath was incorporated to cool the recycle sent back to
the crystallizer and mitigate rapid fouling and encrustation
following nucleation. The baffled heat exchanger has a high
surface, which leads to rapid removal of heat from the incoming
feed solution. It is an important modification to the MSMPR
unit because it prevents a large temperature difference from
developing when hot solution from the dissolver enters the
crystallizer held at a much lower temperature to provide the
driving force for crystallization.
Figure 2 shows the detrimental effect of fouling observed
during preliminary development experiments with the closed-
loop MSMPR design, without the heat exchanger modification.
Severe fouling and crust formation occurred on the PAT probes
and vessel walls of the MSMPR crystallizer.
2.1. Automated Intelligent Decision Support System.
A Kaiser RamanRxn instrument with 785 nm laser, fitted with
RXN 1-784 immersion probe (iC Raman 4.1 software for data
analysis and visualization), was used to obtain spectra for the
development of a multivariate calibration model for solution-
phase concentration measurements using Thermo Scientific
TQ Analyst, version 8, chemometrics software package. The
solution phase was also tracked using a Carl Zeiss MSC621
ATR-UV/vis spectrometer fitted with a Helma ATR 661.822-
UV probe. The unit was coupled with an in-house-developed
LabView software program. Lasentec’s D600L FBRM unit with
an immersion probe (used with Mettler Toledo FBRM
software, version 6.7.0) and V819 PVM unit fitted with an
immersion probe (used with Mettler Toledo PVM image
acquisition software, version 8.3) were used to track the particle
properties of the system. CryPRINS together with the
integrated PAT array (ATR-UV/vis (with a multivariate
calibration model) and FBRM) and ancillary PAT (in situ
Raman (with a multivariate calibration model) and PVM) was
used as an automated intelligent decision support (IDS)
system. The IDS framework shown in Figure 3 was used to
control temperature, monitor solution concentration, track the
particle size, and shape properties of the continuous
crystallization process. The IDS is also able to detect any
system deviations due to perturbations caused, for example, by
transfer line blockages, flow rate changes and fouling, or
impurity build-up. These effects are easily captured because of
large temperature variations that occur from the process set
point or, in the case of impurities, as changes in the Raman and
ATR-UV/vis signals, respectively. The CryPRINS interface in
the IDS provided connectivity to the integrated PAT array, and
the display feature allowed for real-time monitoring of sensor
signals and the determination of steady-state operation in the
MSMPR. The interface also allows for the implementation of
various control strategies to achieve a desired crystallization
outcome, as demonstrated previously in batch crystallization
studies by Saleemi et al.34 and Bakar et al.35
Figure 2. Fouling and crust formation on (left) PAT probe and (right)
MSMPR vessel walls observed during the continuous crystallization of
PCM using the closed-loop crystallizer design without heat exchanger.
Figure 3. Automated intelligent decision support (IDS) system with
integrated and ancillary PAT arrays and CryPRINS software used for
connectivity to PAT tools, process monitoring, and temperature
control.
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2.2. Continuous Crystallization Studies. The continuous
unseeded cooling crystallization experiments were carried out
in the single-stage MSMPR unit with recycle stream in a closed
loop (Figure 1) using only a small amount of material. At start-
up, a suspension of 0.232 g PCM/g IPA in the MSMPR was
heated at 65 °C and held for 15 min to allow complete
dissolution of PCM. The resulting solution was then cooled to
45 °C while simultaneously heating a solution of pure IPA in
the dissolver to the same temperature. Once both vessels
reached 45 °C, the solution in each was pumped continuously
between them using Masterflex peristaltic pumps at a rate of 60
g/min to homogenize the vessel contents. In effect, this created
a closed-loop system, in which the final solution concentration
was 0.152 g PCM/g IPA (Tsat = 35 °C). Once the contents of
the vessels were homogenized, as determined by real-time
concentration measurement using multivariate calibration
models developed with Raman and ATR-UV/vis (linked to
CryPRINS) probes,34 solution from the dissolver/feed vessel
was sent to the baffled tube heat exchanger, where it was cooled
from 45 to 20 °C before entering the MSMPR crystallizer,
which was controlled at 10 °C. This start-up strategy led to
generation of supersaturation required to drive primary
nucleation and produce the initial start-up slurry while
preventing rapid crust formation. The MSMPR was maintained
at 10 °C and the dissolver was maintained at 45 °C for the
duration of each experimental run (Figure 1b). The ATR-UV/
vis multivariate calibration model used for real-time concen-
tration measurement and result display in CryPRINS was of the
form
= + + +b b d b T b dTc o 1 2 3 (1)
where c is the concentration in (g PCM/g IPA), T is the
process temperature (°C), bo, b1, b2, and b3 are fitted regression
coefficients with values of −0.0290, −3.7889, −0.0002, and
−0.0248, respectively, and d is the first derivative of the
absorbance at the selected wavelength (266 nm). The first
derivative of the absorbance is used because it removes baseline
offsets in the spectra. In addition, a simple nonlinear term
expressed as the product of the derivative of the absorbance and
temperature is included to improve the accuracy of the
calibration model. Further details on the model development
using ATR-UV/vis can be found in previous works.34,36
Continuous crystallization control experiments with no
additive added were carried out using the experimental start-
up and operating procedures described earlier. Once the system
was operational, slurry from the MSMPR outlet was
continuously withdrawn and dissolved completely in the
dissolver vessel, and the resulting solution was recycled back
to the MSMPR. The flow rates employed are shown in Figure
1b and resulted in mean residence times (RTs) of 12.12 and
6.38 min in the MSMPR and dissolver vessels, respectively. The
duration of each experiment was approximately 4.6 h (inclusive
of the start-up period). The process was operated for
approximately 18 RTs from the point of nucleation detection
in the MSMPR.
Experiments with additive addition were carried out in a
similar way to the experiments in which no additive was added
(control experiments) using the MSMPR crystallizer setup
shown in Figure 1. HPMC was added to the system to prevent
fouling and encrustation over time and alleviate problems that
were encountered during the initial development stages of the
MSMPR (Figure 2). Three concentrations of HPMC were
investigated, 0.001, 0.003, and 0.05 wt % (expressed as a mass
percentage of HPMC relative to the mass of PCM initially
charged into the MSMPR). For each experiment, the required
amount of HPMC was added to the MSMPR at the start of the
15 min homogenization period. For the experiment in which
0.05 wt % HPMC was added, the dissolver temperature was
elevated to 50 °C. This was due to incomplete dissolution of
small amounts of large crystals, as observed from visual
inspection of material flowing through the recycle transfer line
during preliminary experimental runs, in which the vessel was
maintained at 45 °C.
2.3. Effect of HPMC on Raman and ATR/UV/Vis
Signals. HPMC was found to have no effect on the Raman
or ATR-UV/vis signals at all applied concentrations. Figure 4
shows the Raman spectra of experiments carried out with 0.05
wt % HPMC and with no HMPC addition at similar PCM
concentrations (0.153 and 0.156 g PCM/g IPA, respectively).
There is no evidence of extra peaks or other spectral features
(such as peak broadening or distortion) related to Raman
scattering effects from HPMC. Therefore, the Raman signal of
PCM can be taken to be independent of the HPMC
concentration. Furthermore, signal changes due to the presence
of interference can be minimized or eliminated by applying
mathematical preprocessing techniques to the data.37
2.4. Raman Calibration Model for Solution Measure-
ments. Raman spectra of PCM dissolved in IPA were collected
using the Kaiser RamanRxn instrument with an RXN 1-784
probe. Spectra were collected in the range 3425−100 cm−1 at a
spectral resolution of 4 cm−1. The number of scans and
exposure time for each sample was 4.9 × 7 s over a total
measurement time of 60 s. PCM−IPA solutions were prepared
at saturation temperatures between 10 and 50 °C. The
saturation temperatures of PCM in IPA were estimated from
solubility data published by Hojjati et al.38 These solubility data
were also used by Saleemi et al.34 in a study on comparative
batch crystallization control strategies using PCM−IPA as a
model system. It is well-known that the presence of additives
can lead to an increase in solubility of paracetamol,39−41 which
subsequently leads to longer induction times41 and suppression
of the nucleation rate.40,41 However, the degree to which
HPMC affects the solubility of PCM is not known. Therefore,
the solubility of PCM in this study is taken to be that of pure
solutions. It is likely the effect of HPMC on PCM solubility is
marginal given the very low concentrations applied in the study.
The model equation used to determine the solubility of PCM
(g PCM/g IPA) in IPA as a function of temperature (°C) was
Figure 4. Raman spectra from solution phase for experiments carried
out with 0.05 wt % HPMC (straight line) and no HPMC (dashed line)
addition at concentrations of 0.153 and 0.156 g PCM/g IPA,
respectively.
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= × + × + ×− − −c T T T( ) 2.742 10 1.328 10 7.202 105 2 3 2
(2)
For the calibration model development and validation,
Raman spectra were collected over a range of different
temperatures (solid-free experiments) and in solid−liquid
suspensions with different solid concentrations (solid-phase
experiments), respectively. ATR-UV/vis and FBRM probes
were used to detect dissolution and nucleation events. TQ
Analyst software was used for Raman spectra pretreatment,
model development, and concentration determination. In total,
2219 spectra were used for model development and validation.
Of these, there were 2009 calibration standards, 150 solid-free
validation standards, and 60 solid−liquid suspension validation
standards. The standard normal variate (SNV), Savitzky−Golay
(for derivatives and smoothing), and partial least-squares
regression (PLSR) options in TQ Analyst were applied to
build the calibration model. SNV compensates for differences in
sample path lengths and minimizes the effects of particle
scattering on the Raman signal.37,42 Savitzky−Golay first-
derivative with seven-point smoothing was then applied, which
provided robust background reduction by eliminating baseline
shifts while emphasizing small spectral features relative to large
ones.37,43,44 PLSR was used to obtain the principal components
(factors) for constructing the model.45,46 A total eight factors
were applied, which allowed sufficient data to be used to
correlate changes in the spectral and concentration data,
respectively. The maximum error between the predicted and
model determined concentration was 3.7%. The root-mean-
square error of prediction (RMSEP)47 between the validation
and calibration data sets was 0.0074 g/g (based on the lowest
concentration measurement).
3. RESULTS AND DISCUSSION
3.1. Continuous Crystallization in the Absence of
HPMC Additive. Several challenges were encountered during
the development stages of the continuous crystallization
apparatus: (1) particle settling and blockage of transfer lines,
particularly near the peristaltic pump, (2) fouling and
encrustation on the walls of the MSMPR and dip tube, and
(3) fouling on PAT probes. These issues were mainly due to
the narrow bore size of transfer lines (3 mm i.d.), the low flow
rate requirement to achieve long residence times, leading to
particle settling, and operation of the MSMPR with
recirculation loop, which resulted in the creation of localized
regions of high supersaturation, uncontrolled nucleation, and
eventually fouling and encrustation. Similar issues were
encountered by other investigators,9,10,48 but they were largely
avoided here by using the modified MSMPR (Figure 1).
However, fouling on the PAT probes and mild encrustation on
the vessel walls persisted over prolonged operation. Figure 5
shows the process time diagram for the control experiment (no
additive). The changes in concentration, temperature, and
FBRM counts/s as well as the point of probe removal and
cleaning due to fouling are shown. Periodic cleaning of the
probes was necessary when fouling was detected to avoid the
recording of erroneous results, a practice often not reported in
the literature.
The crystallization proceeded without any washout issues,
which is often reported in the literature.19 This is attributed to
the start-up method employed that was described in Section
2.2. During the nucleation phase, there is a rapid increase in
FBRM counts/s and the CSD changes dynamically, as indicated
by the square-weighted chord length distribution (SWCLD)
data shown in Figure 6a. After approximately 127 min (6th RT
onward), the FBRM counts stabilize and the system arrives at a
steady-state mean particle size and CSD. This is confirmed by
overlapping of the SWCLD from the 6th to 18th RT onward, as
shown in Figure 6b.
The Raman concentration data (Figure 5) paints a different
picture of the process when compared to the FBRM total
counts/s and SWCLD data. There is a decreasing trend from
the onset of nucleation (0.153 g PCM/g IPA) to the end of the
experiment (0.089 g PCM/g IPA). The ATR-UV/vis data also
indicated that the concentration was decreasing over the period.
Figure 7 shows the phase diagram of the process, showing the
trajectory of concentration (measured by ATR-UV/vis) and
temperature changes. At the point of intersection with the
indicative metastable curve, nucleation is observed. The final
recorded concentration of the process, indicated with a dot, is
Figure 5. Time diagram showing temperature, FBRM counts/s, and
Raman concentration measurements obtained from the MSMPR. The
start-up phase is indicated as the initial period prior to nucleation.
Points in the process where fouling was detected on the PAT probes
are circled.
Figure 6. Evolution of FBRM square-weighted chord length
distribution (SWCLD) from (a) the 1st to 5th RT, which indicates
the dynamic state of change in the MSMPR, and (b) the 6th to 18th
RT, which indicates that the MSMPR is at steady state.
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close to the solubility curve, indicating that the process is close
to equilibrium. It appears that the FBRM probe is indicating
steady-state behavior of the system due to particles sticking on
to the surface (Figure 5). This is an important observation and
suggests that relying on just a single PAT to monitor steady-
state behavior can lead to erroneous results.
Raman and ATR-UV/vis with their respective multivariate
calibration models gave similar concentration measurements.
The concentration data from both methods indicated that the
system was in a dynamic state of change and that steady state
had not been attained. This is an important observation since
many recent studies on the subject of continuous crystallization
monitoring characterized steady state by relying solely on
FBRM9,18,32,49−51 and/or imaging techniques (for example, low
angle light scattering (LALLS) and PVM19,51) or calibration-
free spectroscopy approaches.9 Arguably, real-time determi-
nation of concentration using multivariate models supported by
online particle measurements provides a more robust measure
of steady-state operation, as opposed to just tracking changes in
FBRM statistics or using calibration-free methods. Since these
are essentially qualitative measures, they may not reliably
determine the attainment of steady-state operation. In some
studies, offline concentration measurements50,52,53 or gravi-
metric mass balance analysis and/or offline particle size
analysis2,48,54 are used to determine steady-state operation.
These methods are not only laborious but also prone to error
due to the amount of sample handing involved. Furthermore,
losses often occur during the sample filtration step. The use of
PAT with multivariate models, as demonstrated here, provides
a robust approach for characterizing the continuous MSMPR
process in addition to using FBRM, and PVM technologies.
Potentially, other image analysis techniques such as bulk video
imaging (BVI)55,56 or endoscopy−stroboscopy57 in concert
with multivariate image analysis methods could replace PVM to
provide more useful information for further process character-
ization, in particular, of nucleation and growth phenomena. The
advantages of multivariate methods are well-documented for
batch processes;23,38,58 however, there remains limited
application in continuous crystallization.
3.2. Continuous Crystallization Studies with HPMC
Additive. Although many of the challenges encountered
during the development stages of the MSMPR were alleviated
by employing the modified configuration (Figure 1), problems
persisted with fouling and mild encrustation in the MSMPR
(Section 3.1). The use of HPMC additive was therefore
explored as a means of eliminating these problems. HPMC is
on the FDA list of substances generally regarded as safe
(GRAS). In a study on the effect of different polymers on the
crystallization of PCM from aqueous solutions, Wen et al.59
showed that HPMC inhibited primary nucleation, perhaps via
interactions with molecules in the bulk solution. They also
found that growth and secondary nucleation were inhibited to a
significant degree due to the adsorption of HPMC on to the
(010) face of monoclinic form I crystals. It was thought that
HPMC developed hydrogen-bonding interactions with PCM
crystals in the direction of the a axis on the (010) face, thereby
disrupting the surface diffusion of PCM molecules in this
direction and changing the etching patterns on the crystal
surface. HPMC was therefore seen as a variable additive to use
for controlling PCM crystallization, thereby preventing fouling
and encrustation in the MSMPR. Figure 8 shows the process
time diagram for the 0.05% HPMC continuous crystallization
experiment. The start-up phase was extended due to the
presence of HPMC, when compared to that of the control
experiment (Section 3.1). Following this is the nucleation phase
where the FBRM counts/s increase rapidly with simultaneous
depletion of concentration. The maximum FBRM counts/s
attained in the nucleation phase was about 2660 counts/s,
which is almost an order of magnitude lower compared to the
maximum value of 23 800 counts/s recorded during the control
experiment. This data indicates that HPMC not only delays the
onset of nucleation in the system but also suppresses it
significantly. These observations corroborate findings from
previous studies21,59,60 on HPMC suppression of PCM
nucleation. The “A and G phase”, as show in Figure 8, refers
to a period when there is both agglomeration (A) and/or
growth (G) taking place, indicated by a decrease in FBRM
counts/s and corresponding decrease in concentration.
Following the A and G phase, the system achieves steady
state whereby the FBRM counts and solute concentration are
stabilized and remain constant for the duration of the
experiment. Agglomeration was not detected in the no additive
experiment (Figure 5); however, due to the extent of fouling on
the FBRM probe in that experiment, it is not entirely clear if it
occurred or not based on the total counts/s data. However,
PVM and microscope images confirmed that there was
significant agglomeration in that experiment.
Compared to the control experiment with no additive added
(Figure 5), the change in concentration from the onset of
nucleation in the MSMPR is small, further indicating that
nucleation is being suppressed. The concentration decreases
gradually from start-up from the level of 0.156 to 0.150 g
PCM/g IPA after 154 min. The steady-state concentration
(0.147 g PCM/g IPA) was reached after approximately 170 min
Figure 7. Phase diagram showing solubility and operating curves and
indicative metastable width for PCM in IPA generate from ATR-UV/
vis calibration model in the CryPRINS interface. Initial (start) and
final (end) recorded concentrations are indicated as dots on the phase
diagram.
Figure 8. Time diagram showing real-time temperature, FBRM
counts, and Raman concentration measurements obtained from the
MSMPR with addition of 0.05% HPMC.
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and was maintained at that level until the end of the
experiment. The FBRM SWCLD also confirmed steady-state
operation was attained, as shown in Figure 9a,b (1st to 15th
RT). The significant overlap of the distributions between the
6th and 15th RT, when combined with knowledge of the solute
concentration from Raman measurements, confirms that the
system is operating at steady state.
Figure 10 shows the phase diagram of the process, which
indicates the region of steady-state operation. Compared to the
control experiment, the steady state and hence the level of
supersaturation is quite high, confirming the effect of HPMC
on growth and nucleation suppression.21,59 Furthermore, there
was a dramatic reduction in the process yield compared to the
no additive experiment. Due to the dramatic effect of 0.05 wt %
HPMC on the delay and suppression of PCM nucleation and
growth rate, further investigations were conducted at lower
concentrations (0.001 and 0.003 wt %). Table 1 gives a
summary of the results from this set of experiments, as well as
those reported in earlier sections of this article. The
supersaturation (S) as reported is defined as ci/c*. The data
shows that there is a direct correlation between HPMC
concentration in the system and induction time. Conversely,
and as expected, there is an inverse correlation between HPMC
concentration and FBRM counts/s data and fractional yield of
crystallization.
The fractional yield (Y) represents the amount of product
obtained from the crystallization process relative to the amount
of available supersaturation and is calculated from
= −
− *
×Y c c
c c
100o i
o i (3)
where co, ci, and c* are the dissolver/feed stream concentration
(g PCM/g IPA), MSMPR steady-state concentration, and
equilibrium concentration at the specified operating temper-
ature, respectively. The data presented in Table 1 shows there
is a direct correlation between the HPMC concentration and
the level of supersaturation at which the MSMPR operates.
Steady state was not observed for either the 0.001 or 0.003 wt
% HPMC additive experiments due to the persistence of
fouling and encrustation problems.
It appears from the results presented in Table 1 that HPMC
is suppressing both the nucleation kinetics and growth kinetics
(to a lesser extent) of PCM. There is a clear decrease in
particles with increasing HPMC concentration, which indicates
a suppression of nucleation. The FBRM mean-square-weighted
chord length (MSWCL) shows only marginal changes in size
with increasing HPMC concentration.
3.3. Characterization of Crystal Properties from FBRM
Statistics and Image Analysis. The crystal properties from
the continuous MSMPR crystallization were investigated
further using FBRM statistical trends, real-time PVM, and
offline microscope image analysis. Figure 11a−d provides a
comparison between the FBRM statistical trends for the control
and 0.05% HPMC additive experiments. These time diagrams
show the fraction of total counts/s for each size range. In the
early stages of each experiment, just following the onset of
nucleation, the 1−5 and 6−25 μm size fractions accounted for
greater than 90% of the total counts/s. However, as growth
becomes the dominant crystallization mechanism, a large
reduction in the smaller size fractions for the 0.05% HPMC
experiment is observed. This compares to a much smaller
reduction in the amount of fine crystals for the control
experiment.
The contribution of each size fraction to the CSD as the
system approaches steady-state operation provides further
evidence of the effect of HPMC on the suppression of
nucleation and subsequent growth of crystals. Figure 11a
further indicates that the 1−5 μm size fraction contributes only
a small amount (approximately 13.1%) to the total counts/s for
the 0.05 wt % HPMC experiment. This compares to a much
larger contribution (approximately 31.3%) to the total counts/s
from crystals in the same size range for the control experiment.
The 6−25 μm fraction contribution to the total counts/s for
the control and 0.5 wt % HPMC additive experiments were
similar (approximately 55 and 50%, respectively). The 27−50
and 54−100 μm fractions combined contributed approximately
35.3% to the steady-state total counts/s for the 0.05 wt %
HPMC experiment, whereas the contribution was only 13.7%
for the control experiment. These results indicate that while
Figure 9. Evolution of FBRM square-weighted chord length
distribution (SWCLD) from (a) the 1st to 5th RT, which indicates
the dynamic state of change in the MSMPR, and (b) the 6th to 15th
RT.
Figure 10. Phase diagram showing solubility, metastable, and
operating curves for PCM in IPA generated using the ATR-UV/vis
model in the CryPRINS interface. The operating curve indicates the
trajectory through the phase diagram as the experiment progresses.
Initial (start) and final (end) recorded concentrations are indicated by
dots on the phase diagram.
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HPMC is suppressing nucleation to a significant degree, much
larger product crystals are obtained compared to the control
experiment. It is likely that due to the severe suppression of
nucleation the few crystals present in the system have less
competition for solute molecules and thus can grow larger.
However, it is likely that the rate of growth of these crystals is
suppressed. Therefore, the overall deduction is that HPMC
suppresses the nucleation as well as growth kinetics of PCM.
Femi-Oyewo and Spring21 studied the effect of HPMC and
other additives on PCM crystallization from aqueous solutions
and reported a high degree of nucleation and crystal growth
inhibition. In this study, microcrystals with low yield were
observed. The investigators reported crystal size reduction from
4.28 mm (length) without HPMC addition (control) to
between 0.3 and 0.42 mm (length) when HPMC additive in the
concentration range 0.1−0.7 wt % was used. In these previous
studies, the effect of HPMC on the product crystal size is rather
dramatic compared to the results reported here. However, this
is not surprising given the much higher concentrations that
were employed in aqueous solution. Trends of the FBRM
mean-square-weighted chord length (MSWCL) statistic shown
in Figure 12 provide further evidence that larger product
crystals are obtained from the 0.05 wt % HPMC experiment
compared to those from the control experiment. The mean size
of crystals at the end of the control experiment was 35.2 μm.
This compares to a mean steady-state crystal size of 60.6 μm for
the 0.05 wt % HPMC experiment.
Real-time PVM images also indicate that there are larger
crystals for the 0.05 wt % HPMC experiment relative to the
control experiment. Figure 13a shows the change in appearance
of crystals from the onset of nucleation (approximately 58 min)
to the end of the control experiment. There is a rapid increase
in the number of crystals up to 130 min, after which the PVM
probe has become saturated due to the high particle density.
On the other hand, Figure 13b shows the change in crystal
properties captured by PVM from the onset of nucleation
(approximately 97 min) to the end of the 0.05 wt % HPMC
experiment. These crystals are clearly larger than those from the
control experiment. PVM also indicates that steady state was
achieved from 170 min onward since the crystals are of similar
size and shape.
Table 1. Summary of Experimental Results Showing the Effect of HPMC Additive on the Continuous Cooling Crystallization of
PCM
HPMC
(wt %)
induction time: from the onset of
cooling (min.)
nucleation phase max. FBRM
(counts/s)
FBRM MSWCL
(μm)
fractional yield of
crystallization (%)
supersaturation
(ci/c*)
0 58 23 800 35.2 98.8 1.015
0.001 59 15 119 61.0 56.6 1.314
0.003 64 7146 63.5 40.7 1.536
0.050 97 2656 60.6 28.0 1.665
Figure 11. Real-time FBRM statistical data showing the fraction of particle counts/s for a range of size fractions for the MSMPR control (no
additive) and 0.05 wt % HPMC experiments: (a) no weighted counts/s 1−5 μm, (b) no weighted counts/s 6−25 μm, (c) no weighted counts/s 27−
50 μm, and (d) no weighted counts/s 54−100 μm.
Figure 12. Real-time FBRM mean-square-weighted chord length
(MSWCL) trends for the 0.05 wt % HPMC and control (no additive)
experiments.
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Offline microscope images also confirmed the differences in
crystal size between the control experiment and the 0.05 wt %
HPMC experiment. Figure 14 shows the microscope images of
samples taken from the control experiment. The images from
70 min to the end of the experiment show a gradual increase in
the crystal sizes. Agglomerated, twinned, and single crystals can
also be observed. PCM also exhibits several crystal habits with
predominantly prismatic, tabular, and cuboid shaped crystals
present. Ristic et al.61 examined the morphology of form I PCM
crystals grown from aqueous solutions and concluded that the
habit changes of PCM were due principally to changes in the
growth mechanism of the (110) and (001) faces, which exhibit
markedly different growth rates at high and low super-
saturations. Crystal growth was found to be dominant on the
(110) face at low supersaturations, which gave way to
increasing dominance of the (001) as the supersaturation
increased. At low supersaturations (<10%), crystals exhibiting a
columnar or prismatic morphology elongated along the (001)
axis, whereas at high supersaturations (>15%), crystals of a
tabular morphology were reported. Wen et al.59,62 later showed
Figure 13. Real-time PVM images captured during (a) the control experiment (no additive) (due to the high particle density after 130 min, it is
difficult to identify individual crystals) and (b) the 0.05 wt % HPMC additive experiment.
Figure 14. Offline microscope images of samples taken from the continuous crystallization experiments: (a) control experiment and (b) 0.05 wt %
HPMC.
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that the mechanism of HPMC effect on PCM morphology was
via hydrogen-bonding interactions. It is likely that HPMC
interacts differently with PCM on the different crystal faces at
high and low supersaturations, leading to the crystal
morphological changes reported in this study. While these are
interesting observations, investigation of those phenomena
related to the crystal habit of PCM in the presence of HPMC
was outside the scope of the study.
Figure 14a,b shows the microscope images of samples taken
from the control experiment and the 0.05 wt % HPMC
experiment, respectively. Comparatively, the crystals obtained
from the latter are significantly larger than those from the
control run. It is also evident that the crystals are
predominantly of a tabular habit with smoother edges, an
indication that HPMC may be affecting the growth rate to a
different degree on each crystal face. The effect of additives on
crystal growth and morphology is well-documented in the
literature.39,63,64 Thompson et al.39 investigated the effect of
structurally related additives on different crystal faces of form I
PCM. They found that the growth of the (001) face, and hence
the crystal morphology, was affected to different extents by
acetanilide and metacetamol additives due to different
interactions with the NHCOCH3 and OH functional groups,
respectively. The microscope images (Figure 14a,b) indicate,
qualitatively, the effect HPMC additive on growth of PCM
crystals in the continuous MSMPR crystallizer. It may be that,
at the applied concentration of HPMC, surface interactions that
lead to suppression of growth on specific crystal faces occurs,
leading to a subsequent change in the crystal habit.
4. CONCLUSIONS
In this study, a modified MSMPR crystallizer configuration that
included a dissolver/feed unit, in-line heat exchanger, and
recirculation loop was employed for the continuous cooling
crystallization of PCM. In this closed-loop operation, slurry is
continuously dissolved and recycled/fed back to the MSMPR,
leading to continuous operation with minimal use of materials.
The heat exchanger was able to minimize, but not completely
eliminate, fouling and encrustation at start-up by reducing the
temperature difference between the recycled solution and the
contents of the MSMPR, leading to prolonged operation.
Furthermore, start-up of the MSMPR was achieved without any
wash-out issues, as are often reported in the literature.9,19
Wash-out was avoided due to the start-up strategy employed,
whereby material is circulated between the dissolver and
MSMPR until nucleation is detected, as opposed to starting up
with a suspension already in the MSMPR.19,51
Experiments were carried out with HPMC additive addition
to further alleviate fouling and encrustation problems
encountered during prolonged operation. More stable oper-
ation of the MSMPR was observed in the presence of HPMC
additive, and steady state was achieved more readily when
compared to that of a control experiment. However, HPMC
shows a significant effect on the suppression of PCM nucleation
and crystal growth (to a lesser extent). In the presence of
HPMC, the product crystals obtained were tabular shaped and
of similar size. For the control experiment in which no HPMC
was added, predominantly fine crystals with a range of different
morphologies were obtained. Direct correlations were observed
among the HPMC concentration, induction time, and MSMPR
steady-state supersaturation, whereas inverse relationship were
found among HPMC concentration, the fractional yield, and
number of particles detected. The combined results indicate
that HPMC is an effective additive for alleviating fouling and
encrustation. However, the penalty or cost is a significant
suppression of nucleation (and growth to a lesser extent),
which then leads to a low yield of crystallization.
The application of an IDS framework with integrated and
ancillary PAT array and informatics software CryPRINS tool
were used to monitoring the MSMPR operation. Robust
multivariate models were applied using Raman and ATR-UV/
vis spectroscopy for solution concentration measurement.
Furthermore, Raman spectroscopy is rarely used in crystal-
lization to monitor solution-phase concentration. The results
further indicate that the combined use of PAT tools within the
IDS framework is essential to measure unambiguously the state
of a crystallization and to determine when steady state is
achieved. The PAT array provides a more robust approach for
characterization of steady state compared to the use of
standalone PAT monitoring frameworks or calibration-free
approaches.
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